Expression of Interleukin-5 and granulocyte-macrophage colony- stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 5, 1997, Pages 1384-1389

  Sousa, Ana R ^b   Lams, Boris E A ^b   Pfister, Rudolf ^b   Christie, Pandora E ^b   Schmitz, Michael ^b   Lee, Tak H ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CROMOGLYCATE DISODIUM; FENOTEROL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; IPRATROPIUM BROMIDE; PREDNISOLONE; REPROTEROL; SALBUTAMOL; THEOPHYLLINE;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MAST CELL; PRIORITY JOURNAL; PROVOCATION TEST; T LYMPHOCYTE;

EID: 0030697863     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.5.9702072     Document Type: Article

References (36)

1. Samter, M., and R. F. Biers. 1968. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 6:975-983.
2. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 143:1025-1029.
3. 4 after lysine-aspirin inhalation in asthmatic subjects. Am. Rev. Respir. Dis. 146:1531-1534.
4. Ferreri, N. R., W. C. Howland, A. D. Stevenson, and M. L. Spiegelberg. 1988. Release of leukotrienes, prostaglandins and histamine into nasal secretions of aspirin-sensitive asthmatics during reactions to aspirin. Am. Rev. Respir. Dis. 137:847-854.
5. Ortolani, C., C. Mirone, A. Fontana, G. C. Folco, A. Miadonna, N. Montalbetti, M. Rinaldi, A. Sala, A. Tedeschi, and D. Valente. 1987. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium meta-bisulphite nasal provocation in intolerant rhinitic patients. Ann. Allergy 59:106-112.
6. Sladek, K., R. Dworski, J. Soja, J. R. Sheller, E. Nizankowowska, J. A. Oates, and A. Szczeklik. 1994. Eicosanoids in bronchoalveolar lavage fluid of aspirin-tolerant patients with asthma after aspirin challenge. Am. J. Respir. Crit. Care Med. 149:940-946.
7. Dahlen, B., and S. E. Dahlen. 1995. Leukotrienes as mediators of airway obstruction and inflammation in asthma. Clin. Exp. Allergy 2:50-54.
8. 4, and histamine in asthmatics. Am. Rev. Respir. Dis. 146:96-103.
9. Picado, C., I. Ramis, J. Rosello, J. Prat, O. Bulbena, V. Plaza, J. M. Montserrat, and E. Gelpi. 1992. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am. Rev. Respir. Dis. 145:65-69.
10. Owen, W. F., R. J. Soberman, T. Yoshimoto, A. L. Scheffer, R. A. Lewis, and K. F. Austen. 1987. Synthesis and release of leukotriene C4 by human eosinophils. J. Immunol. 138:532-538.
11. MacGlashan, D. W. J., R. P. Schleimer, S. P. Peters, E. S. Schulman, G. K. Adams, H. H. Newball, and L. M. Lichtenstein. 1982. Generation of leukotrienes by purified human lung mast cells. J. Clin. Invest. 70:747-751.
12. Nasser, S. M. S., R. Pfister, P. E. Christie, A. R. Sousa, J. Barker, M. Schmitz-Schumann, and T. H. Lee. 1996. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am. J. Respir. Crit. Care Med. 153:90-96.
13. Sousa, A. R., R. Pfister, S. J. Lane, S. M. Nasser, P. E. Christie, M. Schmitz-Schumann, and T. H. Lee. 1997. Expression of COX1 and COX2 on aspirin-sensitive (ASA) and non-aspirin-sensitive (NASA) asthmatic and normal bronchial mucosa (abstract). J. Allergy Clin. Immunol. 97:A542.
14. Burke, L. A., M. P. Hallsworth, T. M. Litchfield, R. Davidson, and T. H. Lee. 1991. Identification of the major activity derived from cultured human peripheral blood mononuclear cells, which enhances eosinophil viability, as granulocyte-macrophage colony-stimulating factor (GM-CSF). J. Allergy Clin. Immunol. 2:226-235.
15. 4 generation by human eosinophils stimulated by ionophore (A23187) as granulocyte-macrophage colony-stimulating factor (GM-CSF). Am. Rev. Respir. Dis. 140:1340-1347.
16. Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167: 219-224.
17. Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltmann, and A. B. Kay. 1992. Interleukin 5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79:2952-2959.
18. Sousa, A. R., R. N. Poston, S. J. Lane, J. A. Nakhosteen, and T. H. Lee. 1993. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am. Rev. Respir. Dis. 147:1557-1561.
19. Chafee, F. H., and G. A. Settipane. 1974. Aspirin intolerance. Frequency in an allergic population. J. Allergy Clin. Immunol. 53:193-199.
20. McDonald, J. R., D. A. Mathison, and D. D. Stevenson. 1972. Aspirin intolerance in asthma: detection by oral challenge. J. Allergy Clin. Immunol. 50:198-207.
21. Yoshimi, R., H. Takamura, K. Takasaki, H. Tsarumoto, and H. Kumagani. 1993. Immunohistological study of eosinophilic infiltration of nasal polyps in aspirin-induced asthma. Nippon Jibinkora Gakkai Kaiho 96:1922-1925.
22. Yamashita, T., H. Tsuji, N. Maeda, K. Tomoda, and T. Kunajawa. 1989. Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinology Suppl.:15-24.
23. Bosso, J. V., L. B. Schwartz, and D. D. Stevenson. 1991. Tryptase and histamine release during aspirin-induced respiratory reactions. J. Allergy Clin. Immunol. 88:830-837.
24. Imokawa, S., A. Sato, M. Taniguchi, M. Toyoshima, K. Nakazawa, H. Hayakawa, and K. Chida. 1992. Sodium cromoglycate nebulized solution has an acute bronchodilative effect in aspirin-intolerant Asthma (AIA). Arerugi. Jap. J. Allergy 41:1515-1520.
25. Martelli, N. A., and G. Usandivaras. 1977. Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation. Thorax 32: 684-690.
26. Szmidt, M., I. Grzeleweka-Rzymowska, J. Roznecki, and J. Grzegaczyk. 1991. Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity. Pneumonologia i Alergologia Polska 59:16-21.
27. Fischer, A. R., M. A. Rosenberg, C. M. Lilly, J. C. Callery, P. Rubin, J. Cohn, E. Israel, and J. Drazen. 1994. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J. Allergy Clin. Immunol. 94:1046-1056.
28. O'Sullivan, S., B. Dahlen, S.-E. Dahlen, and M. Kumlin. 1996. Increased urinary secretion of the prostaglandin D2 metabolite 9α,11β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J. Allergy Clin. Immunol. 98:421-432.
29. Walsh, G. M., F. A. Symon, and A. J. Wardlaw. 1995. Human eosinophils preferentially survive on tissue fibronectin compared with plasma fibronectin. Clin. Exp. Allergy 25:1128-1136.
30. Lamkhioued, B., D. Aldebert, A. S. Gounni, E. Delaporte, M. Goldman, A. Capron, and M. Capron. 1995. Synthesis of cytokines by eosinophils and their regulation. Int. Arch. Allergy Immunol. 107:122-123.
31. Aldebert, D., B. Lamkhioued, C. Desaint, A. S. Gounni, M. Goldman, A. Capron, L. Prin, and M. Capron. 1996. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators. Blood 87:2354-2360.
32. Desreumaux, P., A. Janin, J. F. Colombel, L. Prin, J. Plumas, D. Emillie, G. Torpier, A. Capron, and M. Capron. 1992. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J. Exp. Med. 175:293-296.
33. Tanaka, Y., E. Delaporte, S. Dubucquoi, A. S. Gounni, E. Porchet, A. Capron, and M. Capron. 1994. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J. Invest. Dermatol. 103:589-592.
34. Dubucquoi, S., P. Desreumaux, A. Janin, O. Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin 5 synthesis by eosinophils: associations with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703-708.
35. Desreumaux, P., A. Janin, S. Dubucquoi, M. C. Copin, G. Torpier, A. Capron, M. Capron, and L. Prin. 1993. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82:1553-1560.
36. Shi, H., S. Qin, G. Huang, Y. Chen, C. Xiao, H. Xu, G. Liang, Z. Xie, X. Qin, J. Wu, G. Li, and C. Zhang. 1997. Infiltration of eosinophils into the asthmatic airways caused by interluekin 5. Am. J. Respir. Cell Mol. Biol. 16:220-224.